Find information on thousands of medical conditions and prescription drugs.

Hepatic encephalopathy

Hepatic encephalopathy is a complication of cirrhosis of the liver and its resultant portal hypertension, toxic substances accumulate in the blood and impair the function of brain cells. Signs can include impaired cognition, a flapping tremor (asterixis), and a decreased level of consciousness. more...

Home
Diseases
A
B
C
D
E
F
G
H
Hairy cell leukemia
Hallermann Streiff syndrome
Hallux valgus
Hantavirosis
Hantavirus pulmonary...
HARD syndrome
Harlequin type ichthyosis
Harpaxophobia
Hartnup disease
Hashimoto's thyroiditis
Hearing impairment
Hearing loss
Heart block
Heavy metal poisoning
Heliophobia
HELLP syndrome
Helminthiasis
Hemangioendothelioma
Hemangioma
Hemangiopericytoma
Hemifacial microsomia
Hemiplegia
Hemoglobinopathy
Hemoglobinuria
Hemolytic-uremic syndrome
Hemophilia A
Hemophobia
Hemorrhagic fever
Hemothorax
Hepatic encephalopathy
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatoblastoma
Hepatocellular carcinoma
Hepatorenal syndrome
Hereditary amyloidosis
Hereditary angioedema
Hereditary ataxia
Hereditary ceroid...
Hereditary coproporphyria
Hereditary elliptocytosis
Hereditary fructose...
Hereditary hemochromatosis
Hereditary hemorrhagic...
Hereditary...
Hereditary spastic...
Hereditary spherocytosis
Hermansky-Pudlak syndrome
Hermaphroditism
Herpangina
Herpes zoster
Herpes zoster oticus
Herpetophobia
Heterophobia
Hiccups
Hidradenitis suppurativa
HIDS
Hip dysplasia
Hirschsprung's disease
Histoplasmosis
Hodgkin lymphoma
Hodgkin's disease
Hodophobia
Holocarboxylase...
Holoprosencephaly
Homocystinuria
Horner's syndrome
Horseshoe kidney
Howell-Evans syndrome
Human parvovirus B19...
Hunter syndrome
Huntington's disease
Hurler syndrome
Hutchinson Gilford...
Hutchinson-Gilford syndrome
Hydatidiform mole
Hydatidosis
Hydranencephaly
Hydrocephalus
Hydronephrosis
Hydrophobia
Hydrops fetalis
Hymenolepiasis
Hyperaldosteronism
Hyperammonemia
Hyperandrogenism
Hyperbilirubinemia
Hypercalcemia
Hypercholesterolemia
Hyperchylomicronemia
Hypereosinophilic syndrome
Hyperhidrosis
Hyperimmunoglobinemia D...
Hyperkalemia
Hyperkalemic periodic...
Hyperlipoproteinemia
Hyperlipoproteinemia type I
Hyperlipoproteinemia type II
Hyperlipoproteinemia type...
Hyperlipoproteinemia type IV
Hyperlipoproteinemia type V
Hyperlysinemia
Hyperparathyroidism
Hyperprolactinemia
Hyperreflexia
Hypertension
Hypertensive retinopathy
Hyperthermia
Hyperthyroidism
Hypertrophic cardiomyopathy
Hypoaldosteronism
Hypocalcemia
Hypochondrogenesis
Hypochondroplasia
Hypoglycemia
Hypogonadism
Hypokalemia
Hypokalemic periodic...
Hypoparathyroidism
Hypophosphatasia
Hypopituitarism
Hypoplastic left heart...
Hypoprothrombinemia
Hypothalamic dysfunction
Hypothermia
Hypothyroidism
Hypoxia
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Pathogenesis

Cirrhosis will obstruct the passage of blood through the liver causing portal hypertension. This means it is difficult for blood from the intestines to go through the liver, to get back to the heart. Portal-systemic anastamoses ("shunts") develop, and portal blood (from the intestinal veins), will bypass the liver, and return to the heart via another route without undergoing first-pass detoxification by the liver. Furthermore, the liver (damaged from the cirrhosis) will not be functioning as well as it should be, so blood that does travel through the liver, may not be as detoxified as it otherwise would be.

The toxic substances involved are not well understood, but have been felt to include ammonia (NH3) and mercaptans. Ammonia is normally converted to urea by the liver, and, as with mercaptans, is produced by the bacterial breakdown of protein in the intestines.

Ammonia can cross the blood-brain barrier, where it causes the support cells of the brain (astrocytes) to swell. The swelling of the brain tissue increases intracranial pressure, and can lead to coma or death via herniation of the brainstem.

Grading of symptoms

Grading of the symptoms of hepatic encephalopathy is as follows:

  • Grade 0 - Clinically normal mental status but minimal changes in memory, concentration, intellectual function, and coordination
  • Grade 1 - Mild confusion, euphoria, or depression; decreased attention; slowing of ability to perform mental tasks; irritability; and disordered sleep pattern, such as inverted sleep cycle
  • Grade 2 - Drowsiness, lethargy, gross deficits in ability to perform mental tasks, obvious personality changes, inappropriate behavior, and intermittent disorientation, usually regarding time
  • Grade 3 - Somnolent but can be aroused, unable to perform mental tasks, disorientation about time and place, marked confusion, amnesia, occasional fits of rage, present but incomprehensible speech
  • Grade 4 - Coma with or without response to painful stimuli

Treatment

It is important to remove excess protein from the lumen of the gut. If there is a gastrointestinal bleed (for instance, ruptured oesophageal varices) this should be stopped, as it serves as a protein supply for bacteria. Dietary intake of protein should be minimised. Special enteral feeding formulations with a high concentration of branched-chain amino acids are sometimes used in therapy, as is parenteral nutrition.

Lactulose is a compound that will cause osmotic diarrhoea, lessening the time bacteria have to metabolise proteins and produce toxic substances. As well as this, it acidifies the bowel, causing ammonia (NH3) to be converted to ammonium (NH4+) which is less readily absorbed. Recent evidence suggests it is not very effective (Als-Nielsen et al 2004).

Read more at Wikipedia.org


[List your site here Free!]


Dietary management of hepatic encephalopathy in cirrhotic patients: survey of current practice in United Kingdom
From British Medical Journal, 5/22/99 by Clare T Soulsby

In the early 1950s it was shown that some patients with cirrhosis given "nitrogenous substances," including excess dietary protein, developed hepatic "precoma."[1] These largely uncontrolled observations led to the introduction of dietary protein restriction to treat hepatic encephalopathy.

Recent research has shown, however, that protein requirements are increased in these patients,[2] that high protein diets are well tolerated, and that their use, particularly in patients who are malnourished, is associated with sustained improvement in mental state.[3 4] In response, the European Society for Parenteral and Enteral Nutrition has recommended that traditional protein restriction should be abandoned in patients with hepatic encephalopathy particularly as other effective treatments are available.[5] We undertook this survey to review the current dietary management of these patients in hospitals throughout the United Kingdom.

Methods and results

We devised and piloted a questionnaire and then sent it to the 110 UK dietetic departments approved by the British Dietetic Association for training student dietitians. Information was requested on the referral, clinical assessment, and dietary management of all inpatients with cirrhosis and hepatic encephalopathy seen in the past 12 months. The questionnaires were returned anonymously. Closed questions were analysed with descriptive statistics and open questions by content analysis.

Seventy one (65%) questionnaires were returned; 64 departments with relevant experience provided details of the dietary management of 1046 patients. Overall, 759 (73%) patients had had their protein intake restricted to some degree (table). In most of these patients the diets were imposed for prolonged periods because treatment end points were not specified or poorly defined. Over half of the responding departments reported requests to restrict protein prophylactically in cirrhotic patients who were neuropsychiatrically unimpaired.

Overall, 261 (25%) patients were referred with a prescriptive request to restrict protein intake; the remaining 758 were referred with a request for dietary advice that allowed leeway for discussion. Nevertheless, the dietitians still felt that 153 (14%) patients had had their protein intake restricted inappropriately (table).

Difficulties were experienced in maintaining oral intake in many of these patients; 58 (91%) of the responding departments reported substantial problems because of anorexia, 17 (27%) because patients were drowsy or confused, and 12 (19%) because the diets were unpalatable. Nevertheless, less than 25% of these patients received appropriate additional nutritional support.

Comment

This survey shows that despite clear recommendations to the contrary,[5] most patients in the United Kingdom with cirrhosis and hepatic encephalopathy have their protein intake restricted, often for prolonged periods. Protein restriction is also widespread in patients thought to be at risk of developing hepatic encephalopathy, which has no justification. Many of these patients are anorexic and find the diets unpalatable and hence unacceptable, yet few are given appropriate nutritional support. In general, dietitians are less in favour of restricting protein intake than the referring doctors, but either their views are not expressed or their advice is not heeded.

The widespread inappropriate dietary management of cirrhotic patients with hepatic encephalopathy is likely to adversely affect outcome. Both dietitians and medical practitioners need to be made aware of recent guidelines,[5] to change current practice, and to work together effectively.

We thank the participating dietitians for completing the questionnaires.

Contributors: CTS initiated the study, designed the original questionnaire, undertook the field work, analysed the data, assisted in writing the paper, and secured the funding. MYM refined the design of the study and the questionnaire, participated in the data analysis, wrote the paper, and is the guarantor.

Funding: The study was partly funded by the British Dietetic Association.

Conflict of interest: None.

[1] Phillips GB, Schwartz R, Gabuzda GJ Jr, Davidson CS. The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances. N Engl J Med 1952;247:239-6.

[2] Nielsen K, Kondrup J, Martinsen L, Dossing H, Larsson B, Stilling B, et al. Long-term oral refeeding of patients with cirrhosis of the liver. Br J Nutr 1995;74:557-67.

[3] Kearns PJ, Young H, Garcia G, Blaschke T, O'Hanlon G, Rinki M, et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 1992;102:200-5.

[4] Morgan TR, Moritz TE, Mendenhall CL, Haas R, and VA Cooperative Study Group #275. Protein consumption and hepatic encephalopathy in alcoholic hepatitis. J Am Coll Nutr 1995; 14:152-8.

[5] Plauth M, Merli M, Kondrup J, Weimann A, Ferenci P, Muller MJ, ESPEN Consensus Group. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr 1997; 16:43-55.

(Accepted 27 August 1998)

Department of Nutrition and Dietetics, Royal Free Hospital, London NW3 2QG

Clare T Soulsby, senior dietitian

University Department of Medicine, Royal Free Hospital and School of Medicine, London NW3 2QG

Marsha Y Morgan, senior lecturer in medicine

Correspondence to: Dr Morgan

BMJ 1999;318:1391

COPYRIGHT 1999 British Medical Association
COPYRIGHT 2000 Gale Group

Return to Hepatic encephalopathy
Home Contact Resources Exchange Links ebay